Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.
Identifieur interne : 000480 ( Ncbi/Curation ); précédent : 000479; suivant : 000481Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.
Auteurs : L E Wallace [Royaume-Uni] ; J. Wright ; D O Ulaeto ; A J Morgan ; A B RickinsonSource :
- Journal of virology [ 0022-538X ] ; 1991.
Descripteurs français
- KwdFr :
- Antigènes HLA-D (immunologie), Antigènes viraux (immunologie), Cellules cultivées, Cellules présentatrices d'antigène (immunologie), Clonage moléculaire, Données de séquences moléculaires, Herpèsvirus humain de type 4 (immunologie), Humains, Lymphocytes T CD4+ (immunologie), Peptides (), Peptides (immunologie), Protéines de l'enveloppe virale (immunologie), Protéines de la matrice virale, Séquence d'acides aminés, Techniques in vitro, Vaccins antiviraux (immunologie), Épitopes.
- MESH :
- immunologie : Antigènes HLA-D, Antigènes viraux, Cellules présentatrices d'antigène, Herpèsvirus humain de type 4, Lymphocytes T CD4+, Peptides, Protéines de l'enveloppe virale, Vaccins antiviraux.
- Cellules cultivées, Clonage moléculaire, Données de séquences moléculaires, Humains, Peptides, Protéines de la matrice virale, Séquence d'acides aminés, Techniques in vitro, Épitopes.
English descriptors
- KwdEn :
- Amino Acid Sequence, Antigen-Presenting Cells (immunology), Antigens, Viral (immunology), CD4-Positive T-Lymphocytes (immunology), Cells, Cultured, Cloning, Molecular, Epitopes, HLA-D Antigens (immunology), Herpesvirus 4, Human (immunology), Humans, In Vitro Techniques, Molecular Sequence Data, Peptides (chemistry), Peptides (immunology), Viral Envelope Proteins (immunology), Viral Matrix Proteins, Viral Vaccines (immunology).
- MESH :
- chemical , chemistry : Peptides.
- chemical , immunology : Antigens, Viral, HLA-D Antigens, Peptides, Viral Envelope Proteins, Viral Vaccines.
- immunology : Antigen-Presenting Cells, CD4-Positive T-Lymphocytes, Herpesvirus 4, Human.
- Amino Acid Sequence, Cells, Cultured, Cloning, Molecular, Epitopes, Humans, In Vitro Techniques, Molecular Sequence Data, Viral Matrix Proteins.
Abstract
Current efforts to develop an Epstein-Barr virus subunit vaccine are based on the major envelope glycoprotein gp340. Given the central role of CD4+ T cells in regulating immune responses to subunit vaccine antigens, the present study has begun the work of identifying linear epitopes which are recognized by human CD4+ T cells within the 907-amino-acid sequence of gp340. A panel of gp340-specific CD4+ T-cell clones from an Epstein-Barr virus-immune donor were first assayed for their proliferative responses to a series of truncated gp340 molecules expressed from recombinant DNA vectors in rat GH3 cells, by using an autologous B lymphoblastoid cell line as a source of antigen-presenting cells. The first four T-cell clones analyzed all responded to a truncated form of gp340 which contained only the first 260 N-terminal amino acids. These clones were subsequently screened for responses to each of a panel of overlapping synthetic peptides (15-mers) corresponding to the primary amino acid sequence of the first 260 N-terminal amino acids of gp340. One clone (CG2.7) responded specifically to peptides from the region spanning amino acids 61 to 81, while three other clones (CG5.15, CG5.24, and CG5.36) responded specifically to peptides from the region spanning amino acids 163 to 183. Work with individual peptides from these regions allowed finer mapping of the T-cell epitopes and also revealed the highly dose-dependent nature of peptide-induced responses, with inhibitory effects apparent when the most antigenic peptides were present at supraoptimal concentrations. Experiments using homozygous typing B lymphoblastoid cell lines as antigen-presenting cells showed that the T-cell clones with different epitope specificities were restricted through different HLA class II antigens; clone CG2.7 recognized epitope 61-81 in the context of HLA DRw15, whereas clones CG5.15, CG5.24, and CG5.36 recognized epitope 163-183 in the context of HLA DRw11. The present protocol therefore makes a systematic analysis of CD4+ T-cell epitopes within gp340 possible; it will be necessary to screen gp340-specific T-cell clones from a variety of donors to assess the wider influence of HLA class II polymorphism upon epitope choice.
PubMed: 1710291
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002992
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002992
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002836
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000480
Links to Exploration step
pubmed:1710291Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.</title>
<author><name sortKey="Wallace, L E" sort="Wallace, L E" uniqKey="Wallace L" first="L E" last="Wallace">L E Wallace</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Cancer Studies, University of Birmingham, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Cancer Studies, University of Birmingham</wicri:regionArea>
<placeName><settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author><name sortKey="Wright, J" sort="Wright, J" uniqKey="Wright J" first="J" last="Wright">J. Wright</name>
</author>
<author><name sortKey="Ulaeto, D O" sort="Ulaeto, D O" uniqKey="Ulaeto D" first="D O" last="Ulaeto">D O Ulaeto</name>
</author>
<author><name sortKey="Morgan, A J" sort="Morgan, A J" uniqKey="Morgan A" first="A J" last="Morgan">A J Morgan</name>
</author>
<author><name sortKey="Rickinson, A B" sort="Rickinson, A B" uniqKey="Rickinson A" first="A B" last="Rickinson">A B Rickinson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1710291</idno>
<idno type="pmid">1710291</idno>
<idno type="wicri:Area/PubMed/Corpus">002992</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002992</idno>
<idno type="wicri:Area/PubMed/Curation">002992</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002992</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002836</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002836</idno>
<idno type="wicri:Area/Ncbi/Merge">000480</idno>
<idno type="wicri:Area/Ncbi/Curation">000480</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.</title>
<author><name sortKey="Wallace, L E" sort="Wallace, L E" uniqKey="Wallace L" first="L E" last="Wallace">L E Wallace</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Cancer Studies, University of Birmingham, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Cancer Studies, University of Birmingham</wicri:regionArea>
<placeName><settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author><name sortKey="Wright, J" sort="Wright, J" uniqKey="Wright J" first="J" last="Wright">J. Wright</name>
</author>
<author><name sortKey="Ulaeto, D O" sort="Ulaeto, D O" uniqKey="Ulaeto D" first="D O" last="Ulaeto">D O Ulaeto</name>
</author>
<author><name sortKey="Morgan, A J" sort="Morgan, A J" uniqKey="Morgan A" first="A J" last="Morgan">A J Morgan</name>
</author>
<author><name sortKey="Rickinson, A B" sort="Rickinson, A B" uniqKey="Rickinson A" first="A B" last="Rickinson">A B Rickinson</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Antigen-Presenting Cells (immunology)</term>
<term>Antigens, Viral (immunology)</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>Cells, Cultured</term>
<term>Cloning, Molecular</term>
<term>Epitopes</term>
<term>HLA-D Antigens (immunology)</term>
<term>Herpesvirus 4, Human (immunology)</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>Molecular Sequence Data</term>
<term>Peptides (chemistry)</term>
<term>Peptides (immunology)</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Matrix Proteins</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antigènes HLA-D (immunologie)</term>
<term>Antigènes viraux (immunologie)</term>
<term>Cellules cultivées</term>
<term>Cellules présentatrices d'antigène (immunologie)</term>
<term>Clonage moléculaire</term>
<term>Données de séquences moléculaires</term>
<term>Herpèsvirus humain de type 4 (immunologie)</term>
<term>Humains</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Peptides ()</term>
<term>Peptides (immunologie)</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines de la matrice virale</term>
<term>Séquence d'acides aminés</term>
<term>Techniques in vitro</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Peptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Viral</term>
<term>HLA-D Antigens</term>
<term>Peptides</term>
<term>Viral Envelope Proteins</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes HLA-D</term>
<term>Antigènes viraux</term>
<term>Cellules présentatrices d'antigène</term>
<term>Herpèsvirus humain de type 4</term>
<term>Lymphocytes T CD4+</term>
<term>Peptides</term>
<term>Protéines de l'enveloppe virale</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antigen-Presenting Cells</term>
<term>CD4-Positive T-Lymphocytes</term>
<term>Herpesvirus 4, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Cells, Cultured</term>
<term>Cloning, Molecular</term>
<term>Epitopes</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>Molecular Sequence Data</term>
<term>Viral Matrix Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cellules cultivées</term>
<term>Clonage moléculaire</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Peptides</term>
<term>Protéines de la matrice virale</term>
<term>Séquence d'acides aminés</term>
<term>Techniques in vitro</term>
<term>Épitopes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Current efforts to develop an Epstein-Barr virus subunit vaccine are based on the major envelope glycoprotein gp340. Given the central role of CD4+ T cells in regulating immune responses to subunit vaccine antigens, the present study has begun the work of identifying linear epitopes which are recognized by human CD4+ T cells within the 907-amino-acid sequence of gp340. A panel of gp340-specific CD4+ T-cell clones from an Epstein-Barr virus-immune donor were first assayed for their proliferative responses to a series of truncated gp340 molecules expressed from recombinant DNA vectors in rat GH3 cells, by using an autologous B lymphoblastoid cell line as a source of antigen-presenting cells. The first four T-cell clones analyzed all responded to a truncated form of gp340 which contained only the first 260 N-terminal amino acids. These clones were subsequently screened for responses to each of a panel of overlapping synthetic peptides (15-mers) corresponding to the primary amino acid sequence of the first 260 N-terminal amino acids of gp340. One clone (CG2.7) responded specifically to peptides from the region spanning amino acids 61 to 81, while three other clones (CG5.15, CG5.24, and CG5.36) responded specifically to peptides from the region spanning amino acids 163 to 183. Work with individual peptides from these regions allowed finer mapping of the T-cell epitopes and also revealed the highly dose-dependent nature of peptide-induced responses, with inhibitory effects apparent when the most antigenic peptides were present at supraoptimal concentrations. Experiments using homozygous typing B lymphoblastoid cell lines as antigen-presenting cells showed that the T-cell clones with different epitope specificities were restricted through different HLA class II antigens; clone CG2.7 recognized epitope 61-81 in the context of HLA DRw15, whereas clones CG5.15, CG5.24, and CG5.36 recognized epitope 163-183 in the context of HLA DRw11. The present protocol therefore makes a systematic analysis of CD4+ T-cell epitopes within gp340 possible; it will be necessary to screen gp340-specific T-cell clones from a variety of donors to assess the wider influence of HLA class II polymorphism upon epitope choice.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000480 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000480 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:1710291 |texte= Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:1710291" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |